{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiemsoooggfwbtdfjusimhgz7ba6eqzzsgqjt7xxy3h3qagx4jgew4",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mgxew5gctfw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic5zmaier4fzdzxgei2ty7xewcoupfcxseuvx6cpgu5mdyh6xfdqq"
    },
    "mimeType": "image/jpeg",
    "size": 13515
  },
  "path": "/2026/03/13/biophytis-lynxkite-alliance-expands-to-turbocharge-ai-driven-drug-discovery-for-next-generation-longevity-therapeutics/",
  "publishedAt": "2026-03-13T15:40:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "Biophytis and LynxKite launch new modalities beyond MASSIVE: AI-driven drug discovery for next-generation longevity therapies This partnership will generate revenue through: A computational longevity platform, including unique curated datasets and accelerated computation methods relevant for longevity research Next-generation drug candidates against sarcopenia Next generation drug candidates for dry age-related macular degeneration SINGAPORE, PARIS and CAMBRIDGE, Mass., March 13, 2026 […]",
  "title": "Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics"
}